Volume : 08, Issue : 08, August – 2021
Title:
21.BIOADHESIVE DRUG DELIVERY SYSTEM-A REVIEW
Authors :
Yerragopu Naga Surekha*, K Lavanya, K Hemalatha, K Anitha, G Ramakrishna
Abstract :
Mucoadhesive drug delivery system are delivery system which utilized the property of the polymers which become adhesive on hydration and hence can be used for targeting a drug to a particular region of the body for extended period of time. Bio adhesion is an interfacial phenomenon in which to materials, at least one of which is is biological, are held together with the interfacial forces. The attachment could be between an artificial material and biological substrate, such adhesion between polymer and a biological membrane. In case of polymer attached to the mucin layer of a mucosal tissue, the term mucoadhesion is used. The mucosal layer lines a number of regions of the body including the gastro intestinal tract, the urogenitial tract, the airways, the ear, nose and eye. These represents potentials sites for attachment of any bio adhesive system and hence, the mucoadhesive drug delivery system includes, buccal, oral, rectal, nasal and ocular delivery systems.
Key words: Bio adhesive dug delivery system (BADDS), Mucin, Bio adhesion, Mucoadhesion.
Cite This Article:
Please cite this article in press Yerragopu Naga Surekha et al, Bioadhesive Drug Delivery System-A Review., Indo Am. J. P. Sci, 2021; 08(8).
Number of Downloads : 10
References:
1. K.P.R.Chowdary A Review on current status on Mucoadhesive Drug Delivery System Indian Drugs 37(9) September 2000 Page No.400-404.
2. S.P.Vyas And Roop K.Khar Controlled Drug Delivery Concepts And Advances page no.257-314.
3. Nagai T, Konishi R, Buccal/gingival Drug Delivery Systems. J Control Release 1987; 6:353-60.
4. Duchene D, Touchard F, Pappas NA. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm 1988;14:283-318.
5. S. B. Patil, R. S. R. Murthy, H. S. Mahajan, R. D. Wagh, S. G. Gattani, Pharm Times,2006, 38(4), 25-28.
6. J Swarbrick, JC. Boylon, “Encyclopedia of Pharmaceutical Technology” Marcel Dekker, Volume-10, 458-460.
7. A Semalty, M Semalty. Pharmainfonet, 2006.
8. N. Vivien, R. Gaurl, Parshoen, M. Madan, Euro J Pharm Biopharm, 2002, 50, 109- B Jasti, X Li, Pharmatech, 2003, 53-58.
9. Smart J.D, The basics and underlying mechanisms of mucoadhesion, Adv. DrugDeliv. Rev., 57 (2005) 1556-1568.
10. R. Khanna, S. P. Agrawal and Alka Ahuja, Indian J pharm sc., 1998, 1, 1-11.
11. Toress D., Cunna, M., Alonso M.J, Euro J Pharm Biopharm, 2001, 51, 199-205.
12. AK. Shingla, M Chawla, A Singh.Drug Devel Indust Pharm, 2000, 9, 913-914.
13. R.Bala Rane sha Chary and Y. Madhusudan Rao, Drug Dev and Ind Pharm, 26 (8), K.P.R.Chowdary A Review on current status on Mucoadhesive Drug Delivery System Indian Drugs 37(9) September 2000 Page No.400-404.
14. Ghandhi R.B.etal 591-594. Drug Delivery Systems. J Control Release 1987; D Tivari, R Sause and PL. Madan; AAPS Pharmscitech, 1999, 1(3), 13.
15. NA Naffee, FA Ismail, NA. Boraje, Drug Devel. Indust. Pharmacy, 2004, Vol. 30 (9), P 995-1004.
16. K.P.R. Chowdary and G.Balatripura Sundari, Indian J. pharm. Sci, 65 (6), 2003, Chowdary K.P.R, and Kamlkara reddy G, Indian Drugs, 39 (4), 2002, 225-229.
17. Lalla J.K and Gurnancy R.A., Indian Drug, 39 (5) (2002), 270-276.
18. Collins E.M, Deasy P.B, MacCarthy D.J, Shanley D.B, Evaluation of a controlled release compact containing tetracycline hydrochloride bonded to tooth for the treatment of periodontal disease, Int. J. Pharm., 51 (1989) 103-114.
19. Samaranayake L.P, Ferguson M.M, Delivery of antifungal agents to the oral cavity, Adv.Drug Deliv. Rev., 13 (1994) 161-179.